Lee's Pharmaceutical Limited clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-14
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.
- Notable: AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment Primary completion date changed from estimate of Dec 28, 2025 to Aug 17, 2026
- Notable: 5-Aminolevulinic Acid for Photodynamic Diagnosis of Malignant Glioma Enrollment reduced: 144 → 79 participants
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-21 | NCT07887490 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant… | Phase 1 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 2 | |
| Phase 3 | 2 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Cervical Cancer (1) · Glioma (1) · Hypertension (1)
Get alerts when Lee's Pharmaceutical Limited's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.